CSIMarket Company Name, Ticker, Industry, else..
 
Nrx Pharmaceuticals Inc   (NASDAQ: NRXP)
 
Price: $3.4000 $0.03 0.890%
Day's High: $3.450000047683716 Week Perf: -0.87 %
Day's Low: $ 3.33 30 Day Perf: -0.14 %
Volume (M): 479,485 52 Wk High: $ 5.05
Volume (M$): $ 0 52 Wk Avg: $2.88
Open: $3.35 52 Wk Low: $1.62



 Market Capitalization (Millions $) 128
 Shares Outstanding (Millions) 38
 Employees 29
 Revenues (TTM) (Millions $) 3
 Net Income (TTM) (Millions $) -22
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 1

Business Description


Nrx Pharmaceuticals Inc is a pharmaceutical company that focuses on developing innovative therapies for various medical conditions. They specialize in the research and development of neurology and psychiatry drugs. The company aims to improve the lives of patients suffering from neurological disorders such as epilepsy, Parkinson's disease, and psychiatric conditions like schizophrenia and depression. Nrx Pharmaceuticals Inc strives to discover novel treatments and bring them to the market to provide better healthcare options to individuals in need.


   Company Address: 1201 Orange Street, Suite 600 Wilmington 19801 DE
   Company Phone Number: 254-6134   Stock Exchange / Ticker: NASDAQ NRXP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALKS   -3.37%    
AMRX   -6.59%    
AXSM        0.57% 
BMRN   -2.18%    
IRWD   -9.98%    
VNDA   -8.86%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 37.72
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.79
Working Capital Ratio 0.9
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.73 $
Revenues (TTM) 0.09 $
Cash Flow (TTM) 0.1 $
Cash 0.71 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 117,034
Net Income per Employee (TTM) -774,586
Receivable Turnover Ratio (TTM) 17.25
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.18

Profitability Ratios Current
Gross Margin (MRQ) 38.69 %
Operating Margin (MRQ) -590.83 %
Net Margin (MRQ) -1500.45 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Nrx Pharmaceuticals Inc's Segments
Therapy    148.23 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.